Quiet but productive: seed checks for prevention and preclinical tools, one neat CE mark, and a fresh EU call. People on the move Qureight / Rebecca Simmons Ex-Riverlane operator becomes COO to scale the Cambridge clinical-trial imaging platform. [Source] NanoSyrinx / Thomas Farrell The UK-based intracellular drug delivery innovator appointed Thomas Farrell as CEO to…
Deal flow picked up: cardiology workflow hardware gets a seasoned chair, obesity tech hits a pivotal milestone, and Europe leans into AI—from a €10m cross-border programme to NICE nudging digital MSK tools forward. People on the move CathVision (Denmark): Eric Thepaut (ex-Boston Scientific EMEA) becomes independent chairman; company also ships ECGenius v3.5 to tighten EP…
The Promise Genomics is drowning in data. A single human genome contains over 3 billion base pairs, and personalised medicine requires mapping not just one genome but entire populations. Quantum algorithms promise to search and analyse these vast datasets faster than classical methods, identifying subtle gene–disease correlations that underpin cancers or rare conditions. The pangenome…